A detailed history of Teacher Retirement System Of Texas transactions in Revolution Medicines, Inc. stock. As of the latest transaction made, Teacher Retirement System Of Texas holds 28,965 shares of RVMD stock, worth $1.7 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
28,965
Previous 25,318 14.4%
Holding current value
$1.7 Million
Previous $983,000 33.47%
% of portfolio
0.01%
Previous 0.01%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

BUY
$36.92 - $47.94 $134,647 - $174,837
3,647 Added 14.4%
28,965 $1.31 Million
Q2 2024

Aug 09, 2024

BUY
$30.14 - $40.68 $81,468 - $109,958
2,703 Added 11.95%
25,318 $983,000
Q1 2024

May 06, 2024

SELL
$26.56 - $33.55 $20,185 - $25,497
-760 Reduced 3.25%
22,615 $729,000
Q4 2023

Feb 07, 2024

BUY
$18.35 - $34.12 $41,067 - $76,360
2,238 Added 10.59%
23,375 $670,000
Q3 2023

Oct 31, 2023

BUY
$25.17 - $35.05 $24,490 - $34,103
973 Added 4.83%
21,137 $585,000
Q2 2023

Jul 19, 2023

SELL
$20.28 - $27.0 $43,013 - $57,267
-2,121 Reduced 9.52%
20,164 $539,000
Q1 2023

May 12, 2023

BUY
$20.76 - $30.09 $77,870 - $112,867
3,751 Added 20.24%
22,285 $483,000
Q4 2022

Feb 10, 2023

SELL
$17.68 - $25.53 $20,225 - $29,206
-1,144 Reduced 5.81%
18,534 $441,000
Q3 2022

Nov 03, 2022

BUY
$17.46 - $26.0 $343,577 - $511,628
19,678 New
19,678 $388,000
Q2 2022

Aug 09, 2022

SELL
$14.54 - $27.17 $141,794 - $264,961
-9,752 Closed
0 $0
Q1 2022

May 09, 2022

BUY
$17.31 - $26.4 $6,231 - $9,504
360 Added 3.83%
9,752 $249,000
Q4 2021

Feb 10, 2022

BUY
$24.35 - $33.7 $44,682 - $61,839
1,835 Added 24.28%
9,392 $236,000
Q3 2021

Nov 09, 2021

BUY
$23.95 - $33.41 $180,990 - $252,479
7,557 New
7,557 $208,000

Others Institutions Holding RVMD

About Revolution Medicines, Inc.


  • Ticker RVMD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 87,697,600
  • Market Cap $5.14B
  • Description
  • Revolution Medicines, Inc., a clinical-stage precision oncology company, focuses on developing therapies to inhibit frontier targets in RAS-addicted cancers. The company is developing RMC-4630, an inhibitor of SHP2, which is in Phase 1/2 clinical trial for the treatment of solid tumors, such as gynecologic and colorectal cancer tumors. It also d...
More about RVMD
Track This Portfolio

Track Teacher Retirement System Of Texas Portfolio

Follow Teacher Retirement System Of Texas and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Teacher Retirement System Of Texas, based on Form 13F filings with the SEC.

News

Stay updated on Teacher Retirement System Of Texas with notifications on news.